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Introduction
The B-13 rat pancreatic cell line is an expandable progenitor-like cell with the capacity to generate an unlimited supply of functional rat hepatocyte-like cells (termed B-13/H cells) in vitro, without the need for animal donors. [1] [2] [3] [4] [5] [6] The cell line appears to be unique in that it differentiates into B-13/H cells that are both qualitatively and quantitatively comparable to freshly isolated hepatocytes. [1] [2] [3] [4] [5] [6] Furthermore, B-13 cells undergo a change to B-13/H cells in response to the addition of a single glucocorticoid hormone, providing a simple and highly reproducible system for hepatocyte generation. 6 In contrast to primary hepatocytes, B-13/H cells remain differentiated for many weeks on plastic substrata, whereas primary hepatocytes rapidly de-differentiate. 6 This latter quality could make B-13/H cells a valuable model for studying hepatic metabolism and toxicity in vitro, since they offer a stable phenotype for studying toxic processes which may take long periods of time to manifest their effects (e.g. low level chronic exposure effects, carcinogenesis).
We have spent the last few years both defining the mechanisms that regulate the differentiation process and putting the B-13 response to glucocorticoid into a physiological context.
We sought to investigate whether the trans-differentiation of acinar cells to hepatocytes is a physiologically feasible outcome in normal cells, both in vitro and in vivo. In a series of papers, we have shown that the B-13 to B-13/H trans-differentiation is regulated by Wnt signalling and serine/threonine protein kinase (SGK1) induction 4, 5 and is related to a pathophysiological response of the rodent pancreas to glucocorticoid. 7, 8 B-13 cells appear to be hyper-responsive to glucocorticoid with respect to hepatic differentiation, but the response occurs in normal rodent pancreas acinar cells as a result of physiologically abnormally high concentrations of glucocorticoid, both in vitro and in vivo. 6 It has yet to be established precisely why pancreatic acinar cells should specifically trans-differentiate into hepatocytes in response to glucocorticoid (in contrast to other tissues which are relatively unaffected). However, it is likely associated with the acinar cell's propensity to revert to a proliferative embryonic ductal phenotype (as seen in vitro 9,10 ; the close developmental relationship between liver and pancreas 11 and the promotion of tissue maturation by glucocorticoids 6 .
Since a long term aim of this program of research is to isolate (or engineer) a human equivalent of the B-13 cell, we examined whether the B-13 response to dexamethasone (DEX) -a synthetic glucocorticoid -is specific to glucocorticoids or whether the response occurs to other steroids. In addition, we sought evidence that an hepatocyte phenotype occurs in human pancreatic cells in vivo and in vitro.
We show that B-13 cells differentiate into B-13/H cells in response to several glucocorticoids but not to a range of other steroid classes. We also demonstrate that long term treatment with glucocorticoid in man results in liver levels of expression of hepatocyte markers in the human pancreas, and that culturing human acinar cells with glucocorticoid also results in expression of genes specific to hepatocytes. These changes were associated with an induction in SGK1 variant gene expression and suggest a human B-13 equivalent is a realistic prospect if the glucocorticoid hyper-responsive mechanism in B-13 cells can be replicated in human cells.
Results
The trans-differentiation of B-13 cells to B-13/H cells is a specific response to glucocorticoid steroids.
The trans-differentiation of pancreatic B-13 cells to hepatocyte-like B-13/H cells in response to dexamethasone includes a change in morphology ( Figure 1A ) and expression of liver-specific mRNAs (cytochrome P450 2E1 [CYP2E1] and carbamoyl phosphate synthase [CPSI]) from undetectable levels as determined by RT-PCR ( Figure 1B) . However, expression of the pancreatic acinar cell marker amylase was retained in B-13/H cells ( Figure 1B) , as previously reported.
1,2
To establish whether trans-differentiation is a response that can occur on exposure to other steroids, the B-13 cell was screened for its response to a range of glucocorticoids and other steroids. Figure 1C demonstrates that B-13 cells responded to the endogenous rat glucocorticoid corticosterone at both normal endogenous (300nM) 12 and elevated Cushing's disease levels (1.5μM )8 as well as to a range other synthetic clinically-employed glucocorticoids: prednisolone, DEX and betamethasone ( Figure 1C ). In contrast, no other steroids or nuclear receptor activators directed the B-13 cells to a B-13/H phenotype (data not shown) or induced the expression of hepatocyte genes ( Figure 1C ). Figure 1C also indicates that B-13/H cells express similar levels of CYP2E1 and CPSI as freshly isolated rat hepatocytes, confirming their quantitative comparability to normal liver hepatocytes in terms of expression levels.
Immunocytochemical staining confirmed that cells B-13/H cells retained expression of both amylase and CYP2E1 and that it was not a sub-set of cells within the culture expressing CYP2E1 only ( Figure 1D ). These data indicate that the appearance of B-13/H cells in vitro is a specific response to glucocorticoids that does not occur in response to other steroids or ligands of other closely-related nuclear receptors, and that B-13/H appearance is dependent on trans-differentiation from acinar cells. Previous work has shown that markers of liver gene expression appear in rodent pancreata [13] [14] [15] [16] and human fetal acinar cells. 17 To establish whether adult human pancreatic tissue is similarly plastic in vivo and responsive to glucocorticoid, tissue from a patient treated for at least 20 years with systemic glucocorticoid (NP10) was compared to tissue from patients with no history of long term systemic glucocorticoid therapy ( Figure 2 ). 
Discussion
The data in this paper demonstrate for the first time that hepatocyte-like cells appear in the adult human pancreas in response to prolonged glucocorticoid exposure. Thus, the pathophysiological response of this tissue to glucocorticoid in rodents (and the mechanisms which regulate it), also exists in man. It is therefore reasonable to predict that if the changes that have occurred in B-13 cells can be replicated in a human pancreatic acinar cell, they will behave similarly to B-13 cells. Such a resource would have extensive utility in a range of toxicity
investigations.
An intriguing question is why hepatocyte-like cells appear in the pancreas in response to excessive glucocorticoid exposure? In addition to their role in playing a regulatory role in metabolism, glucocorticoids have an important role in cellular differentiation. Glucocorticoid levels are low in the developing fetus because placental 11β hydroxysteroid dehydrogenase 2 inactivates maternal glucocorticoid. 18 In humans and many animal species, there is a rise in glucocorticoid concentrations during late pregnancy that parallels the increased maturity of fetal organs. 19 The importance of glucocorticoids in development is clearly illustrated in the lung, where therapeutic use reduces the incidence of respiratory distress in premature birth. 20, 21 It is likely therefore, that normal glucocorticoid concentrations promote the maturation of tissues toward a neonatal phenotype. This is supported by empirical observations with stem cell differentiation to mature cell types and has resulted in glucocorticoid frequently being incorporated into media designed to promote differentiation to mature phenotypes. [22] [23] [24] [25] [26] Since pancreatic tissue is a default state of differentiation for embryonic pancreatic cells capable of being directed toward an hepatic phenotype, 27 it is likely that the mechanism(s) which promotes this process remains functional in 
Materials and methods

Human Tissues
Human liver and pancreas tissue was obtained with patient consent and with approval of the
Newcastle & North Tyneside 2 Research Ethics Committee and the Wales Research Ethics
Committee respectively (see Table 1 for patient details). Human liver tissue was prepared from the margins of tissue removed from patients having a resection for both benign and malignant tumours.
RT-PCR.
Total RNA was purified using Trizol (Invitrogen, Paisley, UK) and RT-PCR performed and analysed essentially as previously outlined. 7 Primer sequences are given in Table 2 . Primer sequences for the amplification of rat sequences have been published previously. 7 Western blotting.
Western blotting was performed essentially as previously outlined 30 with antibodies described previously. [6] [7] [8] Detection was achieved using an ECL kit (Amersham, UK).
Immunohistochemistry.
Tissues were fixed in formalin and processed for immunohistochemistry as previously outlined with antigen retrieval using 0.01M citrate buffer. 30 Tissue sections were then incubated with 3% H2O2
for 10 minutes at room temperature (RT) to quench endogenous peroxide activity, and then washed (Sigma -A5420) both at a 1:200 dilution. Samples were washed twice in 1xPBS before colour development was carried out using BCIP®/NBT substrate system followed by Liquid DAB+ substrate chromogen system for CYP2E1 (alkaline peroxidase activity) and Amylase (HRP activity) expression respectively. In all cases control sections were stained without primary antibody incubation for each individual antibody used. After colour development slides were rinsed briefly in H2O and counterstained using nuclear fast red (Vector laboratories) when required.
Samples were sequentially dehydrated through 50%, 75%, 95%, 100% ethanol and finally into xylene before mounting in depex™.
Cell Isolation and Culture.
Acinar cells were obtained as by-products of human islet isolation as described previously 31 Tissue at the margins of the resection with a normal macroscopic appearance, and as far away from the tumor as possible, were sampled in these studies. For pathology archived block samples -HP1 and HP2 -which were only available as fixed tissue -see figure 3 legend. 
